FDA Releases Guidance on Collecting Race and Ethnicity Data in Clinical Trials

Summary

The Food and Drug Administration (FDA) has made available a guidance document outlining recommendations for collecting and reporting race and ethnicity data in clinical trials conducted in the US and abroad for FDA-regulated products, in compliance with the 1998 Demographic Rule.